These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17048352)

  • 1. What is new in breast cancer? The expanding role of aromatase inhibitors.
    Hakulinen T; Untch M; Farmer R;
    Gynecol Endocrinol; 2006 Jun; 22 Suppl 2():1-13. PubMed ID: 17048352
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent evidence about aromatase in the breast carcinoma].
    Suzuki T; Moriya T; Sasano H
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():106-10. PubMed ID: 17682147
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intracrinology of human breast carcinoma and aromatase].
    Sasano H; Miki Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():81-6. PubMed ID: 17682143
    [No Abstract]   [Full Text] [Related]  

  • 4. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
    Sánchez-Muñoz A; Ribelles N; Márquez A; Pérez-Ruiz E; Alba E
    J Clin Oncol; 2009 Dec; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
    [No Abstract]   [Full Text] [Related]  

  • 5. Aromatase inhibitors in breast cancer.
    Hiscox S; Davies EL; Barrett-Lee P
    Maturitas; 2009 Aug; 63(4):275-9. PubMed ID: 19577386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen producing enzymes and mammary carcinogenesis: a review.
    Subramanian A; Salhab M; Mokbel K
    Breast Cancer Res Treat; 2008 Sep; 111(2):191-202. PubMed ID: 17934808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aromatase inhibitors in breast cancer therapy].
    Joensuu H
    Duodecim; 2004; 120(11):1301-4. PubMed ID: 15327081
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aromatase inhibitors for metastasing breast cancer in postmenopausal women. A survey of a Cochrane review].
    Aziz M; Skougaard K; Kamby C; Nielsen DL
    Ugeskr Laeger; 2008 Jun; 170(25):2248-52. PubMed ID: 18565316
    [No Abstract]   [Full Text] [Related]  

  • 9. Aromatase inhibitors and bone health.
    Bundred NJ
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):60-7. PubMed ID: 19125005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of postmenopausal status, age of the breast cancer patients and the outcome of aromatase inhibitors treatment.
    Aksoy S; Dizdar O; Altundag K
    Breast; 2008 Oct; 17(5):433-5. PubMed ID: 18565752
    [No Abstract]   [Full Text] [Related]  

  • 11. The potential adverse effects of aromatase inhibitors on wound healing: in vitro and in vivo evidence.
    Howgate DJ; Gamie Z; Panteliadis P; Bhalla A; Mantalaris A; Tsiridis E
    Expert Opin Drug Saf; 2009 Sep; 8(5):523-35. PubMed ID: 19645634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging bone health issues in women with breast cancer in Hawai'i.
    Carney JF; Davis J
    Hawaii Med J; 2007 Jun; 66(6):164-6. PubMed ID: 17621865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant use of endocrine therapy in breast cancer.
    Macaskill EJ; Dixon JM
    Breast J; 2007; 13(3):243-50. PubMed ID: 17461898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer.
    Iwase H
    Breast Cancer; 2008; 15(4):278-90. PubMed ID: 18810576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials.
    Boccardo F; Rubagotti A; Aldrighetti D; Buzzi F; Cruciani G; Farris A; Mustacchi G; Porpiglia M; Schieppati G; Sismondi P
    Cancer; 2007 Mar; 109(6):1060-7. PubMed ID: 17295293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatase and the breast: regulation and clinical aspects.
    Miller WR
    Maturitas; 2006 Jul; 54(4):335-41. PubMed ID: 16730141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer in men: should aromatase inhibitors become first-line hormonal treatment?
    Nordman IC; Dalley DN
    Breast J; 2008; 14(6):562-9. PubMed ID: 19000052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen.
    Freedman GM; Anderson P; Li T; Ross E; Swaby R; Goldstein L
    Cancer; 2006 Dec; 107(11):2552-8. PubMed ID: 17061250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aromatase inhibitors in advanced breast cancer].
    Spinelli GP; Tomao F; Miele E; Pasciuti G; Russillo M; Tomao S
    Recenti Prog Med; 2008 Jan; 99(1):34-8. PubMed ID: 18389871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitors in the management of early breast cancer: the TEAM trial.
    Markopoulos C
    Eur J Surg Oncol; 2009 Mar; 35(3):333. PubMed ID: 18455358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.